Literature DB >> 2941208

The plasma release of atrial natriuretic peptide in man.

J V Anderson, J Donckier, W J McKenna, S R Bloom.   

Abstract

We studied plasma atrial natriuretic peptide (ANP) concentrations in seven normal subjects after the acute intravenous infusion of sodium chloride/potassium chloride solution (saline). Three separate infusions of 6, 12 and 18 ml of saline/kg body weight each significantly increased the circulating concentration of ANP without changes of plasma osmolality or electrolyte concentrations. The mean maximal rise of the plasma ANP concentration after the three saline infusions was significantly correlated (r = 0.74, P less than 0.001) with, but occurred 10-30 min later than, the maximal atrial pressure rise. These observations are in accord with the hypotheses that: (a) ANP is a circulating natriuretic factor; (b) atrial distension is an important stimulus to ANP release in man.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941208     DOI: 10.1042/cs0710151

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  20 in total

1.  The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting.

Authors:  Osman Saribulbul; Ilker Alat; Senol Coskun; Anil Z Apaydin; Tahir Yagdi; Mefkure Kiliccioglu; Emin Alp Alayunt
Journal:  Tex Heart Inst J       Date:  2003

Review 2.  Therapeutic role of bosentan in hypertension: lessons from the model of perinephritic hypertension.

Authors:  J E Donckier
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

3.  The interaction of plasma renin activity and plasma atrial natriuretic peptide in 21-hydroxylase deficiency patients.

Authors:  C M R Germano; M de Castro; J C Crescencio; L Gallo; J Antunes-Rodrigues; A C Moreira; L L K Elias
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

4.  Immunocytochemical studies of cardiac myocytes and other non-neuronal cells of the fetal human heart in culture.

Authors:  C J Hassall; R Penketh; C Rodeck; G Burnstock
Journal:  Anat Embryol (Berl)       Date:  1990

5.  Effects of octreotide on cardiovascular hormones and haemodynamics in conscious dogs.

Authors:  J Donckier; L Stoleru; P Selvais; L Galanti; H Van Mechelen; J M Ketelslegers; A A Charlier
Journal:  J Endocrinol Invest       Date:  1996-02       Impact factor: 4.256

6.  The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study.

Authors:  J V Anderson; P W Woodruff; S R Bloom
Journal:  Br Heart J       Date:  1988-02

7.  Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency.

Authors:  L Meleagros; J S Gibbs; M A Ghatei; S R Bloom
Journal:  Br Heart J       Date:  1988-07

8.  Atrial natriuretic peptide and sodium homeostasis in chronic renal failure.

Authors:  T Tulassay; W Rascher; K Schärer
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

Review 9.  Interactions between atrial natriuretic factor and the autonomic nervous system.

Authors:  C C Lang; A D Struthers
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

Review 10.  Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.

Authors:  A C Tan; F G Russel; T Thien; T J Benraad
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.